Molecular Mechanisms Regulating LPS-Induced Inflammation in the Brain

Area of Science:

• Neuroscience
• Immunology
• Molecular Biology

Background:

• Neuroinflammation is a key factor in neurodegenerative diseases, modulated by the cholinergic anti-inflammatory pathway via the alpha7 nicotinic acetylcholine receptor (α7 nAChR).
• Previous studies indicated that LPS or α7 nAChR fragment immunization reduces α7 nAChR density, exacerbating inflammation, beta-amyloid buildup, and memory decline, mimicking early Alzheimer's disease (AD).

Purpose of the Study:

• To elucidate the molecular mechanisms of LPS and antibody effects on the brain.
• To investigate the role of α7 nAChR and its associated pathways in LPS-induced neuroinflammation.

Main Methods:

• Utilized an in vivo model of acute LPS-induced inflammation in mice.
• Employed an in vitro model using cultured glioblastoma U373 cells.
• Analyzed changes in α7 nAChR, acetylcholinesterase (AChE), brain mitochondria, and microRNA profiles.

Main Results:

• LPS challenge decreased α7 nAChR and AChE levels, sensitized brain mitochondria, and altered microRNA profiles towards pro-apoptotic and anti-inflammatory states.
• α7 nAChR-specific antibodies prevented specific miRNA elevations during LPS challenge, maintained mitochondrial resistance, and supported α7 nAChR/AChE decreases.
• In U373 cells, both LPS and α7-specific antibodies stimulated interleukin-6 via the p38/Src pathway.

Conclusions:

• Acute LPS-induced inflammation activates the brain's cholinergic anti-inflammatory pathway, but α7 nAChR down-regulation impairs this protective mechanism.
• α7 nAChR-specific antibodies can exacerbate neuroinflammation by increasing IL-6 and reducing anti-inflammatory miRNAs.
• Despite aggravating inflammation, these antibodies may offer neuroprotection by preserving mitochondrial function and reducing pro-apoptotic miRNAs.